Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Smart Insulin Pens Market Outlook

The global smart insulin pens market size was valued at USD 83.86 million in 2023, driven by the increasing prevalence of diabetes across the globe. The market is anticipated to grow at a CAGR of 12.3% during the forecast period of 2024-2032 to achieve a value of USD 237.45 million by 2032.

Smart Insulin Pens: Introduction

Smart insulin pens are used by people with diabetes to inject insulin. These easy-to-use pens are different from conventional insulin injections. These smart pens use sensors and internal memory to track and record insulin doses for a patient. Insulin pens are built so that they can also be paired with devices such as smart phone applications for better accessibility of the data that has been recorded.

Some of the insulin pens even have setups to set reminders and alerts for administering insulin. Users who use these features are better able to maintain healthy diabetes management and follow their insulin schedule. Some of the insulin pens even have setups to set reminders and alerts for administering insulin. Users who use these features are better able to maintain healthy diabetes management and follow their insulin schedule.

Global Smart Insulin Pens Market Analysis

The trends in the market include the increasing investments that are being made by the manufacturers in research and development to introduce new features and functionalities in smart insulin pens to the users. Due to the smart connectivity feature of these smart pens, developments have been undergoing to make them more connectivity efficient and connect them with even more devices instead of just smart phones, watches among others driving the global smart insulin pens market expansion. Data management from the data generated by the smart insulin pens has been a trend running in the market. The data that is generated by these pens can be used by doctors to provide a better and personalized conclusion current status of health. This data can be used by the users to optimize their treatment and management plans.

Global Smart Insulin Pens Market Segmentations

Market Breakup by Products

  • Smart Insulin Pens 
  • Adaptors for Conventional Pens 
  • Disposable 
  • Reusable

Market Breakup by Type

  • First Generation Pens 
  • Second Generation Pens

Market Breakup by Connectivity Type

  • Bluetooth 
  • USB

Market Breakup by Application

  • Type 1 Diabetes 
  • Type 2 Diabetes

Market Breakup by Region

  • North America 
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East and Africa

Smart Insulin Pens Market Overview

The global market for smart insulin pens is experiencing an evident growth due to the increasing prevalence of diabetes and the rising demand for more effective and user-friendly insulin delivery systems. Smart inulin pens are positioned to play a crucial role in promoting treatment adherence, improving diabetes management results, and ultimately improving the quality of life for people with diabetes as the industry continues to develop.

Additionally, the increased technological advancements in smart insulin pens, including connectivity with smartphone apps, data integration, and insulin dose calculation algorithms, are further propelling the smart insulin pens market growth. The integration of smart insulin pens with digital health platforms and electronic health records is also capable of enhancing the efficiency of diabetes management. Furthermore, the increasing emphasis on personalized medicine and patient-centered care is driving the demand for smart insulin pens in the market due to the customized insulin delivery they provide.

Overall, the smart insulin pens market development is likely to be driven by the diabetic population increase, technology advances, and the need for better diabetes management becomes paramount. The need for improved insulin management and enhanced glycaemic control, among diabetes patients, is driving the adoption of smart insulin pens by healthcare professionals and patients. These devices include useful features, such as dose tracking, dose memory, and reminders, that helps patients follow their insulin regimens and better manage their blood sugar levels.

Smart Insulin Pens Market: Competitor Landscape

The key features of the market report include market landscape, patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Emperra GmbH  
  • Medtronic Plc 
  • Novo Nordisk  
  • Pendiq  
  • Sanofi FA 
  • Berlin-Chemie AG 
  • Bigfoot Biomedical  
  • Digital Medics Pty Ltd. 
  • Eli Lilly and Company  
  • Jiangsu Deflu Medical Device Co. Ltd.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Products
  • Type
  • Connectivity Type
  • Application
  • Region
Breakup by Products
  • Smart Insulin Pens 
  • Adaptors for Conventional Pens 
  • Disposable 
  • Reusable
Breakup by Type
  • First Generation Pens 
  • Second Generation Pens
Breakup by Connectivity Type
  • Bluetooth 
  • USB
Breakup by Application
  • Type 1 Diabetes 
  • Type 2 Diabetes
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Emperra GmbH  
  • Medtronic Plc 
  • Novo Nordisk  
  • Pendiq  
  • Sanofi FA 
  • Berlin-Chemie AG 
  • Bigfoot Biomedical  
  • Digital Medics Pty Ltd. 
  • Eli Lilly and Company  
  • Jiangsu Deflu Medical Device Co. Ltd.

Smart Insulin Pens Market Report Snapshots

Smart Insulin Pens Market Size

Smart Insulin Pens Market Analysis

Smart Insulin Pens Companies

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The market attained a value of about USD 83.86 million in 2023, driven by increased advancement in insulin devices.

The market size is anticipated to grow at a CAGR of 12.3% during the forecast period of 2024-2032, and likely to reach a market value of USD 237.45 million by 2032.

The rising incidence of diabetes, along with the affordability and accessibility of the therapeutic products and services, are the major factors aiding the market growth.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

The components in the market include smart insulin pens, adaptors for conventional pens disposable, and reusable.

The types of insulin pens include first generation and second-generation pens.

The applications can be for type 1 diabetes and type 2 diabetes.

The different connectivity types in the market includes Bluetooth and USB.

Key players involved in the market are Medtronic Plc, Novo Nordisk, Pendiq, Sanofi FA, Berlin-Chemie AG, Bigfoot Biomedical, Digital Medics Pty Ltd., Eli Lilly and Company., Jiangsu Deflu Medical Device Co. Ltd., and Emperra GmbH.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124